Silicon Biosystems
Research groups and companies are developing and applying tools to enrich for and capture CTCs to diagnose tumors early and monitor patients during treatment.
Menarini-Silicon Biosystems Completes Acquisition of Janssen CTC System
The purchase from Janssen of a liquid biopsy test for circulating tumor cells marks Menarini-Silicon's entry into the US diagnostics market.
Menarini-Silicon Biosystems to Acquire Cellsearch CTC Platform From Janssen Diagnostics
Cellsearch is the only FDA-cleared circulating tumor cell test and is used to help manage patients with metastatic breast, prostate, and colorectal cancers.